- Home
- MRUS vs HHH Comparison
MRUS vs HHH Comparison
Compare MRUS & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- HHH
- Stock Information
- Founded
- MRUS 2003
- HHH 2010
- Country
- MRUS Netherlands
- HHH United States
- Employees
- MRUS N/A
- HHH N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- MRUS Health Care
- HHH Real Estate
- Exchange
- MRUS Nasdaq
- HHH Nasdaq
- Market Cap
- MRUS 5.1B
- HHH 4.7B
- IPO Year
- MRUS 2016
- HHH N/A
- Fundamental
- Price
- MRUS $96.19
- HHH $89.30
- Analyst Decision
- MRUS Buy
- HHH Buy
- Analyst Count
- MRUS 17
- HHH 2
- Target Price
- MRUS $94.94
- HHH $90.00
- AVG Volume (30 Days)
- MRUS 1.3M
- HHH 380.0K
- Earning Date
- MRUS 10-31-2025
- HHH 11-10-2025
- Dividend Yield
- MRUS N/A
- HHH N/A
- EPS Growth
- MRUS N/A
- HHH 234.52
- EPS
- MRUS N/A
- HHH 5.10
- Revenue
- MRUS $56,606,000.00
- HHH $1,834,033,000.00
- Revenue This Year
- MRUS $52.81
- HHH N/A
- Revenue Next Year
- MRUS N/A
- HHH $21.07
- P/E Ratio
- MRUS N/A
- HHH $17.56
- Revenue Growth
- MRUS 57.54
- HHH 69.81
- 52 Week Low
- MRUS $33.19
- HHH $61.41
- 52 Week High
- MRUS $96.28
- HHH $91.07
- Technical
- Relative Strength Index (RSI)
- MRUS 72.69
- HHH 66.05
- Support Level
- MRUS $95.74
- HHH $82.48
- Resistance Level
- MRUS $96.18
- HHH $91.07
- Average True Range (ATR)
- MRUS 0.36
- HHH 2.65
- MACD
- MRUS -0.39
- HHH 0.49
- Stochastic Oscillator
- MRUS 89.43
- HHH 81.83
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.